Cite
MLA Citation
Claudia Kedor et al.. “Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.” Annals of the rheumatic diseases, vol. 79, no. 8, 2020, pp. 1090–1097. http://access.bl.uk/ark:/81055/vdc_100127573128.0x000062